Christine Hale

Pharmacokinetic Evaluation of CYP3A4‐Mediated Drug‐Drug Interactions of Isavuconazole With Rifampin, Ketoconazole, Midazolam, and Ethinyl Estradiol/Norethindrone in Healthy Adults

Robert Townsend, Albert G. H. Dietz, Christine Hale et al. · Clinical Pharmacology in Drug Development · 2016 · 109 citations · Full text

An open-label, single-dose, phase 1 study of the absorption, metabolism and excretion of quizartinib, a highly selective and potent FLT3 tyrosine kinase inhibitor, in healthy male subjects, for the treatment of acute myeloid leukemia

Madhu Sanga, Joyce James, Joseph Marini et al. · Xenobiotica · 2016 · 31 citations

The brinker repressor system regulates injury-induced nociceptive sensitization in <i>Drosophila melanogaster</i>

Aidan McParland, Julie K Moulton, Courtney Brann et al. · Molecular Pain · 2021 · 29 citations · Full text

Two Phase 1, Open‐Label, Mass Balance Studies to Determine the Pharmacokinetics of ¹⁴C‐Labeled Isavuconazonium Sulfate in Healthy Male Volunteers

Robert Townsend, Kota Kato, Christine Hale et al. · Clinical Pharmacology in Drug Development · 2017 · 24 citations · Full text

Absorption, Metabolism, and Excretion of [¹⁴C]‐Tivozanib, a Vascular Endothelial Growth Factor Receptor Tyrosine Kinase Inhibitor, in Healthy Male Participants: A Phase I, Open‐Label, Mass‐Balance Study

Monette Cotreau, Christine Hale, Lindsey Jacobson et al. · Clinical Pharmacology in Drug Development · 2012 · 15 citations